Skip to main content
Log in

Improvement in strategies for the non-invasive prenatal diagnosis of Huntington disease

  • GENETICS
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

We focused on the improvements of prenatal diagnosis by the analysis of DNA from maternal plasma, using Huntington disease as a model of disease.

Methods

We studied plasma from a pregnancy at risk of having a fetus affected with Huntington disease by the use of two direct analysis of the mutation and polymorphic STRs.

Results

Direct methods were not informative. Analysis with STRs revealed the presence of the allele that does not co-segregate with the disease, thus the fetus was healthy.

Conclusions

This strategy is very useful to face complex cases when the direct study is not informative not only for Huntington disease but also for many other disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Lo YM. Fetal RhD genotyping from maternal plasma. Ann Med. 1999;31(5):308–122.

    Article  PubMed  CAS  Google Scholar 

  2. Johnson KL, Dukes KA, Vidaver J, LeShane ES, Ramirez I, Weber WD, Bischoff FZ, Hahn S, Sharma A, Dang DX. Interlaboratory comparison of fetal male DNA detection from common maternal plasma samples by real-time PCR. Clin Chem. 2004;50(3):516–21. doi:10.1373/clinchem.2003.024380.

    Article  PubMed  CAS  Google Scholar 

  3. Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, Haines CJ, Redman CW. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem. 1999;45(2):184–8.

    PubMed  CAS  Google Scholar 

  4. Gonzalez-Gonzalez MC, Garcia-Hoyos M, Trujillo MJ, Rodriguez de Alba M, Lorda-Sanchez I, Diaz-Recasens J, Gallardo E, Ayuso C, Ramos C. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn. 2002;22:946–8. doi:10.1002/pd.439.

    Article  PubMed  CAS  Google Scholar 

  5. Gonzalez-Gonzalez MC, Trujillo MJ, Rodriguez de Alba M, Garcia-Hoyos M, Lorda-Sanchez I, Diaz-Recasens J, Ayuso C, Ramos C. Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR. Prenat Diagn. 2003;23:232–4. doi:10.1002/pd.570.

    Article  PubMed  CAS  Google Scholar 

  6. Gonzalez-Gonzalez MC, Trujillo MJ, Rodriguez de Alba M, Ramos C. Early Huntington disease prenatal diagnosis by maternal semiquantitative fluorescent-PCR. Neurology. 2003;60:1214–5.

    PubMed  CAS  Google Scholar 

  7. Sekizawa A, Saito H. Prenatal screening of single-gene disorders from maternal blood. Am J Pharmacogenomics. 2001;1(2):111–7. doi:10.2165/00129785-200101020-00004.

    Article  PubMed  CAS  Google Scholar 

  8. Andrew SE, Goldberg YP, Theilmann J, Zeisler J, Hayden MRA. CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: implications for diagnostic accuracy and predictive testing. Hum Mol Genet. 1994;3(1):65–7. doi:10.1093/hmg/3.1.65.

    Article  PubMed  CAS  Google Scholar 

  9. Bustamante-Aragones A, Rodriguez de Alba M, Gonzalez-Gonzalez C, Trujillo-Tiebas MJ, Diego-Alvarez D, Vallespin E, Plaza J, Ayuso C, Ramos C. Foetal sex determination in maternal blood from the seventh week of gestation and its role in diagnosing haemophilia in the foetuses of female carriers. Haemophilia. 2008;14(3):593–8. doi:10.1111/j.1365-2516.2008.01670.x.

    Article  PubMed  CAS  Google Scholar 

  10. Creighton S, Almqvist EW, MacGregor D, Fernandez B, Hogg H, Beis J, Welch JP, Riddell C, Lokkesmoe R. Predictive, pre-natal and diagnostic genetic testing for Huntington’s disease: the experience in Canada from 1987 to 2000. Clin Genet. 2003;63(6):462–475. assay. Prenat Diagn. 2007;27(1):11–17. doi:10.1002/pd.1608

    Google Scholar 

  11. Jasper MJ, Hu DG, Liebelt J, Sherrin D, Watson R, Tremellen KP, Hussey ND. Singleton births after routine preimplantation genetic diagnosis using exclusion testing (D4S43 and D4S126) for Huntington’s disease. Fertil Steril. 2006;85(3):597–602. doi:10.1016/j.fertnstert.2005.08.050.

    Article  PubMed  CAS  Google Scholar 

  12. Huang DJ, Zimmermann BG, Holzgreve W, Hahn S. Improvement of methods for the isolation of cell-free fetal DNA from maternal plasma: comparison of a manual and an automated method. Ann N Y Acad Sci U S A. 2006;1075:308–12. doi:10.1196/annals.1368.041.

    Article  CAS  Google Scholar 

  13. Li Y, Page-Christiaens GC, Gille JJ, Holzgreve W, Hahn S. Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay. Prenat Diagn. 2007;27(1):11–7. doi:10.1002/pd.1608.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

F.I.S. supported this project (PI040218). We thank Foundation Conchita Rábago for their support to MC González-González and Ana Bustamante Aragonés. F.I.S. and Foundation Conchita Rábago approved and agreed to be named in the acknowledgments of this paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Cristina González-González.

Additional information

Capsule Prenatal diagnosis of single gene disorders such as Huntington disease are possible using maternal blood and different simple laboratory techniques.

Rights and permissions

Reprints and permissions

About this article

Cite this article

González-González, M.C., Garcia-Hoyos, M., Trujillo-Tiebas, M.J. et al. Improvement in strategies for the non-invasive prenatal diagnosis of Huntington disease. J Assist Reprod Genet 25, 477–481 (2008). https://doi.org/10.1007/s10815-008-9256-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-008-9256-8

Keywords

Navigation